Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer

Background: Gastric cancer (GC) is the fifth most common malignancy and the third leading cause of tumor-related deaths globally. Herein, we attempted to build a novel immune-related gene (IRG) signature that could predict the prognosis and immunotherapeutic efficiency for GC patients. Methods: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dongliang, Xu, Yuanmin, Fang, Yu, Hu, Kongwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186121/
https://www.ncbi.nlm.nih.gov/pubmed/35692814
http://dx.doi.org/10.3389/fgene.2022.885553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186121/
https://www.ncbi.nlm.nih.gov/pubmed/35692814
http://dx.doi.org/10.3389/fgene.2022.885553

Ejemplares similares